TB-500: community reports and studied uses

Summary

Researchers studied TB-500, a synthetic fragment of thymosin beta-4, in tissue-repair, flexibility, and recovery models. In community settings, members reported using it during recovery-focused periods and reported observations over time.

Studied for

• Soft-tissue and muscle repair
• Tendon and ligament flexibility
• Recovery after strain or injury
• Inflammation in research models
• Hair and skin observations

What researchers studied the compound for.

Reported effects

• Faster perceived recovery reported Frequently reported
• Reduced joint and tendon discomfort reported Commonly reported
• Greater perceived flexibility reported Commonly reported
• Calmer, more settled feeling reported Sometimes reported
• Hair or skin observations reported Rarely reported

Frequency of report describes how often members reported an effect, not how often it occurs or whether it is expected.

Side effects and tolerability

• Injection-site irritation Mild
• Temporary tiredness or head-heavy feeling after a dose Occasional
• Head-rush or lightheadedness reported Rare

Observational. Members reported these; they are not expected outcomes.

Duration-of-use observations

Members most often described their use in multi-week recovery blocks. Many noted they mentioned it more in the earlier part of a block and less often later. Reported patterns varied widely between individuals and research contexts.

Describes reported patterns of use. Not a schedule, target, or recommended duration.

Mechanism-of-action notes

Research literature describes thymosin beta-4 in the context of actin regulation, cell migration, and angiogenesis. These are mechanisms studied in models, not confirmed outcomes in people.

Reconstitution arithmetic

Example arithmetic only: a 5 mg vial reconstituted with 2 mL of bacteriostatic water gives 2.5 mg per mL, so 0.2 mL drawn from that vial contains 0.5 mg. Arithmetic only, not a dose recommendation.

Arithmetic only: mg, mL, and volumes. This is not a dosing protocol.

Co-occurrence in research protocols

Reflects co-occurrence in the site research protocols. Not interaction-safety or contraindication data.